0001104659-24-101618 Sample Contracts
ContractWarrant Agreement • September 20th, 2024 • Camp4 Therapeutics Corp • Pharmaceutical preparations • California
Contract Type FiledSeptember 20th, 2024 Company Industry JurisdictionTHIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
Standard Contracts
LEASE AGREEMENTLease Agreement • September 20th, 2024 • Camp4 Therapeutics Corp • Pharmaceutical preparations • Massachusetts
Contract Type FiledSeptember 20th, 2024 Company Industry JurisdictionTHIS LEASE AGREEMENT (this “Lease”) is made as of this 3 day of October, 2019, between ARE-MA REGION NO 59, LLC, a Delaware limited liability company (“Landlord”), and CAMP4 THERAPEUTICS CORPORATION, a Delaware corporation (“Tenant”).
LEASE 4888 PEARL EAST CIRCLE Boulder, CO BCSP PEARL EAST PROPERTY LLC, a Delaware limited liability company as Landlord, and CAMP4 THERAPEUTICS CORPORATION, a Delaware corporation as Tenant.Lease Agreement • September 20th, 2024 • Camp4 Therapeutics Corp • Pharmaceutical preparations • Colorado
Contract Type FiledSeptember 20th, 2024 Company Industry JurisdictionThis Lease (the “Lease”), dated as of the Execution Date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between BCSP PEARL EAST PROPERTY LLC, a Delaware limited liability company (“Landlord”), and CAMP4 THERAPEUTICS CORPORATION, a Delaware corporation (“Tenant”).
THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • September 20th, 2024 • Camp4 Therapeutics Corp • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 20th, 2024 Company Industry JurisdictionTHIS THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of June 3, 2022, by and among Camp4 Therapeutics Corporation, a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.